Tags

Type your tag names separated by a space and hit enter

CRISPR-Cas9 and the Promise of a Better Future.
Eur J Health Law. 2019 Oct 04; 26(4):308-329.EJ

Abstract

Due to its simplicity, low cost and accuracy, CRISPR-Cas9 has become a promising new technique in the field of gene editing. However, despite its virtues, it is not yet immune to scientific hazards and ethical legal concerns. These concerns have been used to justify opposition to genetic manipulation, and have led to some regulations to ban or impose a moratorium based on the precautionary principle. In Europe, regulation mostly comes from the European Union and the Council of Europe, both very cautious towards gene editing. In this article, two arguments on the future legal framework of CRISPR-Cas9 are made. The first is that continued research will contribute to more scientific accuracy; thus, the precautionary principle should promote regulated research to achieve this aim. The second is that most of the legal and ethical concerns surrounding CRISPR-Cas9 are based on unfounded prejudice emanating from a mystical understanding of the human genome.

Authors+Show Affiliations

Faculty of Law, University of Macau Macau China.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

31597119

Citation

Raposo, Vera Lúcia. "CRISPR-Cas9 and the Promise of a Better Future." European Journal of Health Law, vol. 26, no. 4, 2019, pp. 308-329.
Raposo VL. CRISPR-Cas9 and the Promise of a Better Future. Eur J Health Law. 2019;26(4):308-329.
Raposo, V. L. (2019). CRISPR-Cas9 and the Promise of a Better Future. European Journal of Health Law, 26(4), 308-329. https://doi.org/10.1163/15718093-12264438
Raposo VL. CRISPR-Cas9 and the Promise of a Better Future. Eur J Health Law. 2019 Oct 4;26(4):308-329. PubMed PMID: 31597119.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - CRISPR-Cas9 and the Promise of a Better Future. A1 - Raposo,Vera Lúcia, Y1 - 2019/10/04/ PY - 2019/10/10/entrez PY - 2019/10/10/pubmed PY - 2020/9/5/medline KW - CRISPR-Cas9 KW - Council of Europe (CoE) KW - European Union (EU) KW - gene editing KW - precautionary principle SP - 308 EP - 329 JF - European journal of health law JO - Eur J Health Law VL - 26 IS - 4 N2 - Due to its simplicity, low cost and accuracy, CRISPR-Cas9 has become a promising new technique in the field of gene editing. However, despite its virtues, it is not yet immune to scientific hazards and ethical legal concerns. These concerns have been used to justify opposition to genetic manipulation, and have led to some regulations to ban or impose a moratorium based on the precautionary principle. In Europe, regulation mostly comes from the European Union and the Council of Europe, both very cautious towards gene editing. In this article, two arguments on the future legal framework of CRISPR-Cas9 are made. The first is that continued research will contribute to more scientific accuracy; thus, the precautionary principle should promote regulated research to achieve this aim. The second is that most of the legal and ethical concerns surrounding CRISPR-Cas9 are based on unfounded prejudice emanating from a mystical understanding of the human genome. SN - 1571-8093 UR - https://www.unboundmedicine.com/medline/citation/31597119/CRISPR_Cas9_and_the_Promise_of_a_Better_Future_ L2 - https://brill.com/doi/10.1163/15718093-12264438 DB - PRIME DP - Unbound Medicine ER -